Latest Merck Stories
ROCKLAND, Massachusetts, July 29, 2014 /PRNewswire/ -- - First patient begins treatment in an international Phase II study investigating the efficacy
"Speaking Up" is Vital, Given the Significant Impact of the Disease on Women WHITEHOUSE STATION, N.J., July 17, 2014 /PRNewswire/ -- Merck (NYSE: MRK), known as MSD outside the United
TUCSON, Ariz., July 10, 2014 /PRNewswire/ -- Ventana Medical Systems, Inc. (Ventana), a member of the
GAITHERSBURG, Md., July 8, 2014 /PRNewswire/ -- Sirnaomics, Inc.
- Investment reflects company's ongoing commitment to innovation in fertility research ROCKLAND, Mass., July 1, 2014 /PRNewswire/ -- EMD Serono, Inc., a subsidiary of Merck KGaA, Darmstadt,
Merkerson Visits Washington, D.C.
- Collaboration and license agreement allows Merck Serono to expand its oncology drug portfolio ROCKLAND, Mass., June 24, 2014 /PRNewswire/ -- EMD Serono, Inc., a subsidiary of Merck
LONDON, June 18, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:
ROCKLAND, Mass., June 11, 2014 /PRNewswire/ -- EMD Serono, Inc., a subsidiary of Merck KGaA, Darmstadt, Germany announced today its commitment to U.S.
Patients with a particularly stubborn type of breast cancer could potentially benefit by supplementing radiation treatments with a generic, low-cost medication commonly prescribed to treat high
- The act of lurking; skulking about; hiding; keeping from sight.